Literature DB >> 1988335

Localization of epidermal growth factor receptor in hepatocyte nuclei.

U Marti1, S J Burwen, A Wells, M E Barker, S Huling, A M Feren, A L Jones.   

Abstract

Experiments undertaken to investigate the binding of epidermal growth factor by hepatocyte nuclei showed that: (a) isolated nuclei from both normal and regenerating rat liver are capable of binding 125I-epidermal growth factor, (b) the nuclear epidermal growth factor-binding protein is similar in molecular weight to the plasma membrane epidermal growth factor receptor, (c) monoclonal antibodies produced against the plasma membrane epidermal growth factor receptor recognize the nuclear epidermal growth factor receptor and (d) the nuclear receptor has an affinity for epidermal growth factor comparable to that of the plasma membrane receptor, but fewer (approximately 10%) nuclear receptors are available per protein unit compared with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988335

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

Review 1.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

2.  Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells.

Authors:  Raymond Reif; Alshaimaa Adawy; Nachiket Vartak; Jutta Schröder; Georgia Günther; Ahmed Ghallab; Marcus Schmidt; Wiebke Schormann; Jan G Hengstler
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

Review 3.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.

Authors:  Y-N Wang; H Yamaguchi; J-M Hsu; M-C Hung
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

Review 4.  Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications.

Authors:  Hui-Wen Lo
Journal:  Discov Med       Date:  2010-07       Impact factor: 2.970

Review 5.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

Review 6.  Spatial regulation of receptor tyrosine kinases in development and cancer.

Authors:  Jessica B Casaletto; Andrea I McClatchey
Journal:  Nat Rev Cancer       Date:  2012-05-24       Impact factor: 60.716

7.  Integrin α4-positive human trophoblast progenitors: functional characterization and transcriptional regulation.

Authors:  O Genbacev; N Larocque; K Ona; A Prakobphol; T Garrido-Gomez; M Kapidzic; A Bárcena; M Gormley; S J Fisher
Journal:  Hum Reprod       Date:  2016-04-15       Impact factor: 6.918

8.  Induction of ERBB2 nuclear transport after radiation in breast cancer cells.

Authors:  Bo Luo; Shiying Yu; Liang Zhuang; Shu Xia; Zhen Zhao; Lei Rong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

9.  Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking.

Authors:  Y Du; J Shen; J L Hsu; Z Han; M-C Hsu; C-C Yang; H-P Kuo; Y-N Wang; H Yamaguchi; S A Miller; M-C Hung
Journal:  Oncogene       Date:  2013-02-04       Impact factor: 9.867

10.  Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer.

Authors:  Yanjun Gu; Shiwu Zhang; Qiang Wu; Shaoyan Xu; Yanfen Cui; Zhengduo Yang; Xiulan Zhao; Baocun Sun
Journal:  J Exp Clin Cancer Res       Date:  2010-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.